Related Experiment Video
Updated: Jun 4, 2026
07:59
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Rubesanolides A and B: diterpenoids from Isodon rubescens
1Guiyang College of Traditional Chinese Medicine, Guiyang 550002, Guizhou, China.
Organic Letters
|February 22, 2011
Summary
Two novel diterpenes, rubesanolides A and B, were isolated from Isodon rubescens. These compounds feature a unique beta-lactone subgroup and unprecedented ring conformations, marking a significant discovery in natural product chemistry.
Area of Science:
- Natural Product Chemistry
- Organic Chemistry
- Medicinal Plant Research
Background:
- Isodon rubescens is a medicinal plant known for its bioactive compounds.
- Diterpenes are a class of natural products with diverse biological activities.
- The structural diversity of natural products continues to expand with new discoveries.
Purpose of the Study:
- To isolate and characterize novel diterpenes from Isodon rubescens.
- To investigate the unique structural features of these newly discovered compounds.
- To determine the absolute configuration of the isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation through comprehensive spectroscopic data analysis (NMR, MS).
- Determination of absolute configuration via X-ray diffraction crystallography.
Main Results:
- Two novel diterpenes, rubesanolides A (1) and B (2), were successfully isolated.
- Both compounds possess a unique beta-lactone subgroup.
- Compound 1 exhibited chair, boat, and twist-chair conformations for rings A, B, and C, respectively—a first for natural diterpenes.
Conclusions:
- Rubesanolides A and B represent a novel class of diterpenes with unique structural characteristics.
- The discovery highlights the potential of Isodon rubescens as a source of new chemical entities.
- The findings expand the understanding of conformational diversity in natural diterpenes.
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...